Junxi Liu

Dr. Junxi Liu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
YLYanjuan Liu
Yanjuan Liu
JLJunxi Liu
Junxi Liu
DDDuolong Di
Duolong Di
MLMin Li
Min Li
YFYan Fen
Yan Fen
Aporphinoid alkaloids, which encompass a large number of complicated structures, are an important group of natural products. The anticancer activity of aporphinoid alkaloids has become a hot pharmaceutical research area in recent years. Recent studies on the anticancer activity of these compounds are reviewed. The structure activity relationships (SARs) and anticancer mechanisms of aporphinoid alkaloids, as well as simple aporphine, oxoaporphine, dehydroaporphine and dimeric aporphine, have been summarized. The presence of a 1,2-methylenedioxy group and methylation of nitrogen are key features to the cytotoxicity of aporphinoid alkaloids. Oxidation and dehydrogenation of C7 could improve the anticancer activity. The contributions of chirality of hydrogen at C6a and the substitution pattern of other positions about aporphinoid alkaloids for anticancer activity remain unknown. Induced cancer cells apoptosis, prevention of cell proliferation, DNA topoisomerase inhibition, reducing the drug-resistant cellular side population (SP) or cancer stem cells (CSCs) and inhibition of epidermal growth factor receptor (EGFR) tyrosine kinase seem to play important roles in the molecular mechanisms of anticancer activity about aporphinoid alkaloids.

12 August 2014 in Molecules
Verified
Journal Article
Open access
PDF file
MZMei Zhong
Mei Zhong
YLYanjuan Liu
Yanjuan Liu
JLJunxi Liu
Junxi Liu
DDDuolong Di
Duolong Di
MXMengrou Xu
Mengrou Xu
JLJinxia Liu
Jinxia Liu
In order to improve the anticancer activity of isocorydine (ICD), ten isocorydine derivatives were prepared through chemical structure modifications, and their in vitro and in vivo activities were experimentally investigated. 8-Amino-isocorydine (8) and 6a,7-dihydrogen-isocorydione (10) could inhibit the growth of human lung (A549), gastric (SGC7901) and liver (HepG2) cancer cell lines in vitro. Isocorydione (2) could inhibit the tumor growth of murine sarcoma S180-bearing mice, and 8-acetamino-isocorydine (11), a pro-drug of 8-amino-isocorydine (8), which is instable in water solution at room temperature, had a good inhibitory effect on murine hepatoma H22-induced tumors. The results suggested that the isocorydine structural modifications at C-8 could significantly improve the biological activity of this alkaloid, indicating its suitability as a lead compound in the development of an effective anticancer agent.

1 April 2020 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
YZYanxia Zhang
Yanxia Zhang
YZYaming Zhang
Yaming Zhang
YHYanming Han
Yanming Han
YTYe Tian
Ye Tian
PWPengcheng Wu
Pengcheng Wu
JLJunxi Liu
Junxi Liu

1 December 2017 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
QYQian Yan
Qian Yan
RLRuxia Li
Ruxia Li
AXAiyi Xin
Aiyi Xin
YHYin Han
Yin Han
YZYanxia Zhang
Yanxia Zhang
DDDuolong Di
Duolong Di

19 November 2014 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
YCYali Chen
Yali Chen
MLMin Li
Min Li
JLJianjun Liu
Jianjun Liu
QYQian Yan
Qian Yan
MZMei Zhong
Mei Zhong
JLJinxia Liu
Jinxia Liu

5 February 2014 in Natural Product Research
Verified
Journal Article
Closed access
MZMei Zhong
Mei Zhong
YMYu-Xi Ma
Yu-Xi Ma
JLJunxi Liu
Junxi Liu
DDDuo-Long Di
Duo-Long Di
Phytochemical investigation of the whole plants of Dicranostigma leptopodum (Maxim) Fedde has led to the isolation of two quaternary protoberberine alkaloids 5-hydroxy-coptisine (1) and berberrubine (2). This type of alkaloids was isolated from the genus Dicranostigma for the first time and the new compound structure (1) was elucidated by various spectroscopic methods including 2D NMR techniques (gCOSY, HMQC and HMBC) and HR-ESI-MS.